Latest Breaking News On - Anna molt - Page 1 : comparemela.com

Patients with rheumatic disease who continued TNF blockers during their pregnancy did not have an increased risk of worse fetal and maternal outcomes and had a lower risk of severe infection.

France generalUnited statesSarak tedeschiAnna moltLeah flatmanAmerican college of rheumatologyHarvard medical schoolMcgill universityAmerican collegeCochin hospitalMedscape medicalHarvard medicalAnti tnfAnti tumor necrosis factorClinical guidelinesOint inflammation